Reply to Stowasser : Assessing How Patients Feel, Function, and Survive in Idiopathic Pulmonary Fibrosis: The Best Is the Enemy of the Good

Raghu G, Ghazipura M, Fleming T, Aronson K, Behr J, Brown K . Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the.... Am J Respir Crit Care Med. 2024; 209(6):647-669. DOI: 10.1164/rccm.202312-2213SO. View